|
Date Submitted:
12/11/07
Hits: 15 Rating: ![]() ![]() ![]() ![]() 0/5 based on 0 votes
FDA to Monitor Post-Market Drug Safety
Description:
In an apparent attempt to address growing criticism of its operations, the U.S. Food and Drug Administration unveiled a set of initiatives Tuesday that are intended to bolster the country's health safety net. The recommendations include a pilot project to assess the safety of drugs after they're on the market, as well as initiatives to improve communication both within and without the beleaguered agency.
Read the Complete Article Similar content: FDA's New Drug Safety Plan Under the Microscope, in Epilepsy Drug Safety: There's No Magic Pill, Study Says, in Multiple Sclerosis Drug Safety: There's No Magic Pill, Study Says, in Multiple Sclerosis Why Obese Men Post Lower PSA Levels, in Prostate Cancer Post-traumatic Epilepsy in Our Military and Among Civilians, in Epilepsy |

